These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 9722070
1. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Paquette RL, Tran L, Landaw EM. Bone Marrow Transplant; 1998 Aug; 22(4):351-7. PubMed ID: 9722070 [Abstract] [Full Text] [Related]
2. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y, Imagama S, Kanie T, Murata M, Taji H, Suzuki R, Morishita Y, Kodera Y. Bone Marrow Transplant; 2004 Jun; 33(11):1143-50. PubMed ID: 15077133 [Abstract] [Full Text] [Related]
3. Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3-4 bone marrow transplant-associated thrombotic microangiopathy. Zeigler ZR, Shadduck RK, Nath R, Andrews DF. Bone Marrow Transplant; 1996 Jan; 17(1):81-6. PubMed ID: 8673060 [Abstract] [Full Text] [Related]
9. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Roy V, Rizvi MA, Vesely SK, George JN. Bone Marrow Transplant; 2001 Mar; 27(6):641-6. PubMed ID: 11319595 [Abstract] [Full Text] [Related]
11. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Cutler C, Li S, Kim HT, Laglenne P, Szeto KC, Hoffmeister L, Harrison MJ, Ho V, Alyea E, Lee SJ, Soiffer R, Sonis S, Antin JH. Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292 [Abstract] [Full Text] [Related]
12. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Zeigler ZR, Shadduck RK, Nemunaitis J, Andrews DF, Rosenfeld CS. Bone Marrow Transplant; 1995 Feb; 15(2):247-53. PubMed ID: 7773214 [Abstract] [Full Text] [Related]
13. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J. Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648 [Abstract] [Full Text] [Related]
18. CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation. Arranz R, Conde E, Rodriguez-Salvanés F, Pajuelo FJ, Cabrera R, Sanz MA, Petit J, Bueno J, Maldonado J, Odriozola J, Conde JG, Brunet S, Carreras E, Iriondo A, Fernández-Rañada JM, Marín P, Subcomité de Aplasia Medular del Grupo Español de Trasplante Hemopoyético. Bone Marrow Transplant; 2002 Feb; 29(3):205-11. PubMed ID: 11859392 [Abstract] [Full Text] [Related]
19. Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation. Srivastava A, Gottlieb D, Bradstock KF. Bone Marrow Transplant; 1995 Jun; 15(6):863-7. PubMed ID: 7581082 [Abstract] [Full Text] [Related]
20. Complete response in severe thrombotic microangiopathy post bone marrow transplantation (BMT-TM) after multiple plasmaphereses. Milone J, Napal J, Bordone J, Etchegoyen O, Morales V. Bone Marrow Transplant; 1998 Nov; 22(10):1019-21. PubMed ID: 9849701 [Abstract] [Full Text] [Related] Page: [Next] [New Search]